The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high ...
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...
Jared Polis reads to preschool kids at the Heaven’s Little Steps Childcare in Grand Junction First Church of the Nazarene ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...
Hosted on MSN6d
New pharma opioid settlement funds will bolster harm reduction, treatment in New York City, officials sayA settlement agreement with Purdue Pharma and members of the Sackler family, could bring in another $250 million to New York ...
Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...
The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback